Exchange: NYSE·Updated 07:57 PM EDT

PG News

News
all
press releases
P&G to Webcast Fireside Chat From the Barclays Global Consumer Staples Conference, September 10
Andre Schulten, Chief Financial Officer of The Procter & Gamble Company (NYSE:PG) will be a featured speaker at the Barclays Global Consumer Staples Conference on Thursday, September 10, 2026, at 8:15 A.M. ET (Eastern Time). Media and investors may access the live audio webcast at...
Business Wire
More News
Procter & Gamble Fabric & Home Care Trends Mixed: Is Growth Ahead?
PG's Fabric & Home Care shows mixed trends as U.S. Fabric Care improves, Home Care slips and innovation lifts growth in Tide.
Zacks
Is P&G Stock Worth Buying as Growth Slows and Valuation Stays Rich?
PG enters fiscal 2027 with modest growth and a valuation premium, as productivity, innovation and robust cash returns support its investment case.
Zacks
P&G Fiscal 2027 Outlook Brings an 8% Core EPS Headwind Into Focus
PG faces an 8% fiscal 2027 core EPS headwind from higher input costs, financing expense, lower non-operating income and currency pressures.
Zacks
The Best Dividend Stock for 2027 and Beyond: Procter & Gamble
Key PointsProcter & Gamble offers a dependable dividend yield and roughly 70 straight years of dividend increases...
Nasdaq News: Markets
Is Procter & Gamble Stock Underperforming the Nasdaq?
Is Procter & Gamble Stock Underperforming the Nasdaq...
Yahoo! Finance: News
Procter & Gamble Has Raised Its Dividend for 70 Straight Years. Here's How Much $25,000 Invested Pays Annually.
Key PointsAlthough several others have track records that match P&G's, only one stock has a longer streak of annual dividend hikes...
Nasdaq News: Markets
How GOJO Could Shape Clorox's Fiscal 2027 Growth and Margin Outlook
CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.
Zacks
Is Clorox Stock Worth Buying as GOJO Growth Meets Margin Pressure?
CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.
Zacks
Clorox Stock Jumps 13.1% in a Month. Can the Gains Keep Building?
CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.
Zacks

Advertisement|Remove ads.